Bio-Techne TECH
NASDAQ TECH
$72.43 -0.02 (-0.03%)
As of: Sep 4, 2026 · 2:19 PM EDT

Bio-Techne (TECH) Assets Average (2010 - 2026)

Bio-Techne (TECH) posted quarterly Assets Average of $2.5 billion for Q1 2026, down 4.54% year-over-year from $2.7 billion in Q1 2025, and little changed quarter-over-quarter from $2.5 billion in Q4 2025.

Analysis

Bio-Techne (TECH) Assets Average (2010 - 2026) Analysis & Trends

Bio-Techne's Assets Average history runs 17 years deep, the most recent figure standing at $2.5 billion for Q1 2026.

  • In Q1 2026, Assets Average fell 4.54% year-over-year to $2.5 billion; the TTM figure through Mar 2026 stood at $2.5 billion (down 4.54% YoY), while the FY2025 annual figure was $2.6 billion, down 1.51% from the prior year.
  • Assets Average for Q1 2026 stood at $2.5 billion, roughly flat from $2.5 billion in the prior quarter.
  • The five-year high for Assets Average was $2.7 billion in Q4 2023, with the low at $2.3 billion in Q2 2022.
  • The 5-year median for Assets Average is $2.6 billion (2025), against an average of $2.6 billion.
  • The sharpest annual moves came in 2023 and 2025: Assets Average grew 16.38% in 2023, then retreated 6.61% in 2025.
  • Bio-Techne's Assets Average stood at $2.4 billion in 2022, then advanced by 16.38% to $2.7 billion in 2023, then retreated by 1.45% to $2.7 billion in 2024, then decreased by 6.61% to $2.5 billion in 2025, then rose by 0.48% to $2.5 billion in 2026.
  • Business Quant data shows TECH's Assets Average at $2.5 billion in Q1 2026, $2.5 billion in Q4 2025, and $2.5 billion in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Vertex Pharmaceuticals 138.92 Bn 131.07 Bn 2.84 Bn 26.95 Bn
2 Regeneron Pharmaceuticals 85.55 Bn 77.56 Bn 3.93 Bn 41.30 Bn
3 Argenx Se 63.55 Bn 58.37 Bn 1.37 Bn -
4 Moderna 58.26 Bn 53.13 Bn 52.00 Mn 11.22 Bn
5 Revolution Medicines 44.08 Bn 44.08 Bn - 3.29 Bn
6 BeOne Medicines 39.98 Bn 34.89 Bn 1.53 Bn 8.86 Bn
7 Alnylam Pharmaceuticals 35.32 Bn 32.01 Bn 992.69 Mn 5.34 Bn
8 Royalty Pharma 28.42 Bn 27.59 Bn - 19.82 Bn
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn 2.09 Bn
10 Bio-Techne 11.30 Bn 11.03 Bn 211.39 Mn 2.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.57 Bn
Mar 31, 2026 2.54 Bn
Dec 31, 2025 2.52 Bn
Sep 30, 2025 2.54 Bn
Jun 30, 2025 2.60 Bn
Mar 31, 2025 2.66 Bn
Dec 31, 2024 2.70 Bn
Sep 30, 2024 2.72 Bn
Jun 30, 2024 2.71 Bn
Mar 31, 2024 2.73 Bn
Dec 31, 2023 2.74 Bn
Sep 30, 2023 2.70 Bn
Jun 30, 2023 2.62 Bn
Mar 31, 2023 2.48 Bn
Dec 31, 2022 2.36 Bn
Sep 30, 2022 2.32 Bn
Jun 30, 2022 2.30 Bn
Mar 31, 2022 2.30 Bn
Dec 31, 2021 2.29 Bn
Sep 30, 2021 2.27 Bn